Clinical trial · Interventional
Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)
NCT06354049CI-TRIAL-00096988completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this research is to investigate the delivery of Reiki to integrative oncology patients and assess its potential for improving cancer-related symptoms in this population.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Pain | — | UNRESOLVED | — |
| Oncology Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Reiki | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Reiki therapy
- description
- This is a feasibility single arm trial of Reiki for oncology participants.
- interventionNames
- Other: Reiki
Primary outcomes (6)
- measure
- Recruitment rate as measured by the percentage of participants enrolled
- timeFrame
- 8 weeks post enrollment
- description
- Calculated by total number of participants enrolled/ total number of participants eligible and 90% is considered successful for the recruitment rate.
- measure
- Retention rate as measured by the number of participants retained until the final survey point
- timeFrame
- 8 weeks post enrollment
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 89 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 - 89. * Neoplasm diagnosis (i.e., ICD-10 C00 - D49) confirmed in electronic health record (EHR)/Caisis * Receiving care at a UH Connor Whole Health Integrative Oncology Clinic. * Reporting at least three ESAS symptoms ≥4/10 at baseline screening including fatigue and ≥2 other symptoms on the 9-item questionnaire. * Able to speak and understand English. * Has an email address, and access to a computer with internet and/or a mobile device with a functioning data plan Exclusion Criteria: * Significant cognitive impairment that has not been corrected. * Significant visual impairment that has not been corrected. * Unable to provide informed consent. * Active psychosis. * Pregnancy. * Metastatic disease. * Reiki therapy within 3 months of study enrollment * Active immunotherapy, chemotherapy, or radiation treatment, or completed within 3 months before study start. Aromatase inhibitors and tamoxifen are exceptions.
References
Publications (0)
Data not yet available
No reference posted for this study.